Error: Could not add to watchlist. X

ImmunoGen Inc

+ Watchlist
IMGN:US
NASDAQ GS
14.38
USD
0.02
0.14%
As of 14:37:33 ET on 07/07/2015.
Open
14.45
Day Range
14.16 - 14.56
Volume
619,655
Previous Close
14.40
52Wk Range
5.34 - 15.88
1 Yr Return
27.39%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.66
Market Cap (b USD)
1.235
Shares Outstanding (m)
86.185
Price/Sales (TTM)
15.78
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
ImmunoGen, Inc. develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology together with its expertise in monoclonal antibodies and tumor biology. A TAP compound uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's purpose-developed cancer-killing agents specifically to tumor cells.
ADDRESS
830 Winter Street
Waltham, MA 02451-1477
United States
PHONE
1-781-895-0600
  • Daniel M Junius "Dan"
    President/CEO
  • David B Johnston "Dave"
    Exec VP/CFO/Treasurer
  • Sandra E Poole
    Senior VP:Technical Operations
  • Charles Q Morris "Charlie"
    Exec VP/Chief Development Officer
  • Anna Berkenblit
    VP/Chief Medical Officer
Show More